It is extremely difficult to actually pinpoint what medicare and medicaid pay for drugs because of the rebate system that is behind the scenes. Either way, look at the annual reports of all the publicly traded pharma companies and realize that they run net profit margins largely in line with utilities. For instance, you look at the information in the clip you posted and you would think "wow, look at this crazy amount of profit they are making" when you see the size of the buybacks etc. What isn't explained there is that a lot of this money isn't profits, it is borrowed. Companies are borrowing money at super low rates and using it to buy back their own stock, for good reason very often. It has been extremely common globally and across all industries.
The biggest problem is that the CEO, or anyone else, isn't willing to come back and check hard with facts and stats.
For instance:
AbbVie Inc. annual income statement. View ABBV financial statements in full, including balance sheets and ratios.
www.wsj.com
The past 5 years ABBV's net income has run in the mid-high $5B annual range, one outlier at $7B because of a one time event, but generally around the 5 handle. Now, that is for a company valued at $206B as of writing this. Does it seem unreasonable to you in that context? That a business returns a 2.5% return based on the capitalization? Or that for 2020 they had a net margin of just under 10%? Do you think the bakery down the street is running a margin under 10%? How would you keep a business afloat if you didn't have at least that margin? Or, consider the fact that ABBV has an R&D expense on an annual basis that is roughly in line with their total amount of net profit, is that not enough?
I would just like someone who wants to beat on a pharma/biotech/any company to read these financials and come back with a response to this before they go after a company with a club like it is a baby seal.